chartexchange

Metagenomi Therapeutics to Present Preclinical Data Supporting MGX-001, a Potential One-Time Therapy for Hemophilia A, in Oral Presentation at 68th American Society of Hematology Annual Meeting

GlobeNewswire Inc. | Nov 4, 2026 9:25 AM EST

MGX-001 data establish preclinical proof-of-concept in hemophilia A On track to initiate global clinical trial in 2027

Read original article